Daiwa Securities Group’s Concert Pharmaceuticals, Inc. CNCE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-193
| Closed | -$1K | – | 1335 |
|
|
2022
Q4 | $1K | Buy |
+193
| New | +$1.01K | ﹤0.01% | 1307 |
|
|
2021
Q4 | – | Sell |
-58
| Closed | – | – | 1474 |
|
|
2021
Q3 | $0 | Hold |
58
| – | – | ﹤0.01% | 1356 |
|
|
2021
Q2 | $0 | Hold |
58
| – | – | ﹤0.01% | 1298 |
|
|
2021
Q1 | $0 | Hold |
58
| – | – | ﹤0.01% | 1297 |
|
|
2020
Q4 | $1K | Buy |
+58
| New | +$661 | ﹤0.01% | 1237 |
|
|
2019
Q4 | – | Sell |
-126
| Closed | -$1K | – | 1262 |
|
|
2019
Q3 | $1K | Hold |
126
| – | – | ﹤0.01% | 1169 |
|
|
2019
Q2 | $2K | Hold |
126
| – | – | ﹤0.01% | 1162 |
|
|
2019
Q1 | $2K | Hold |
126
| – | – | ﹤0.01% | 1148 |
|
|
2018
Q4 | $2K | Hold |
126
| – | – | ﹤0.01% | 1116 |
|
|
2018
Q3 | $2K | Hold |
126
| – | – | ﹤0.01% | 1135 |
|
|
2018
Q2 | $2K | Hold |
126
| – | – | ﹤0.01% | 1152 |
|
|
2018
Q1 | $3K | Buy |
+126
| New | +$2.8K | ﹤0.01% | 1108 |
|
Daiwa Securities Group's CNCE Position: Q1 2023 in Review
Daiwa Securities Group sold out of Concert Pharmaceuticals, Inc. (CNCE) in Q1 2023, closing a stake of 193 shares — an estimated $1K sold.
Daiwa Securities Group first reported a position in CNCE in Q1 2018 and held it in 12 quarters. The position peaked at $3K in Q1 2018. 0 funds tracked by Wall St. Rank hold CNCE as of Q1 2023.
- Daiwa Securities Group reported no remaining Concert Pharmaceuticals, Inc. position as of Q1 2023 after selling out during the quarter.
- Daiwa Securities Group sold 193 Concert Pharmaceuticals, Inc. shares in Q1 2023, an estimated $1K.
- Daiwa Securities Group first reported a position in Concert Pharmaceuticals, Inc. in Q1 2018 and held it in 12 quarters.
- Daiwa Securities Group's Concert Pharmaceuticals, Inc. position peaked at $3K in Q1 2018.
- 0 funds tracked by Wall St. Rank held Concert Pharmaceuticals, Inc. as of Q1 2023.
Based on Daiwa Securities Group's 13F filing for Q1 2023, filed 2 May 2023.